| JYSB2100097 | 甲型肝炎灭活疫苗（人二倍体细胞） | Hepatitis A Vaccine,Inactivated | Injection | Biological Products | Supplementary Application | 2021-04-10 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-27 | view |
| JYSB2100098 | 四价人乳头瘤病毒疫苗（酿酒酵母） | Human Papillomavirus Quadrivalent Vaccine | Injection | Biological Products | Supplementary Application | 2021-04-10 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-04-09 | view |
| JYSB2100095 | 甲型肝炎灭活疫苗（人二倍体细胞） | Hepatitis A Vaccine,Inactivated | Injection | Biological Products | Supplementary Application | 2021-04-10 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-27 | view |
| JYSB2100094 | 甲型肝炎灭活疫苗（人二倍体细胞） | Hepatitis A Vaccine,Inactivated | Injection | Biological Products | Supplementary Application | 2021-04-10 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-27 | view |
| JYSB2100099 | 四价人乳头瘤病毒疫苗（酿酒酵母） | Human Papillomavirus Quadrivalent Vaccine | Injection | Biological Products | Supplementary Application | 2021-04-10 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-04-09 | view |
| JYSB2100096 | 甲型肝炎灭活疫苗（人二倍体细胞） | Hepatitis A Vaccine,Inactivated | Injection | Biological Products | Supplementary Application | 2021-04-10 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2022-01-27 | view |
| JYSB2100086 | 四价人乳头瘤病毒疫苗（酿酒酵母） | Human Papillomavirus Quadrivalent Vaccine | Injection | Biological Products | Supplementary Application | 2021-03-25 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | Certificate Issued | 2021-11-19 | view |
| JYSB2100087 | 四价人乳头瘤病毒疫苗（酿酒酵母） | Human Papillomavirus Quadrivalent Vaccine | Injection | Biological Products | Supplementary Application | 2021-03-25 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | Certificate Issued | 2021-11-19 | view |
| JXSB2100028 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-03-24 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-03-23 | view |
| JYHB2100180 | 泊沙康唑注射液 | posaconazole | Injection | Chemical Drugs(5.1) | Supplementary Application | 2021-03-10 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-03-09 | view |
| JXSB2100017 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-03-02 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-03-01 | view |
| JXSB2100013 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-02-20 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-02-19 | view |
| JYHB2100138 | 泊沙康唑肠溶片 | posaconazole | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-02-11 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | Certificate Issued | 2021-03-04 | view |
| JXHL2100046 | MK-8189 | MK-8189 | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-02-09 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-02-09 | view |
| JYHB2100127 | 注射用达托霉素 | daptomycin | Lyophilized | Chemical Drugs | Supplementary Application | 2021-02-05 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-02-05 | view |
| JYHB2100128 | 注射用达托霉素 | daptomycin | Lyophilized | Chemical Drugs | Supplementary Application | 2021-02-05 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-02-05 | view |
| JYSB2100036 | 帕博利珠单抗注射液 | Pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-01-28 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-01-27 | view |
| JXHB2100015 | MK-7264 | gefapixant | Injection | Chemical Drugs(1) | Supplementary Application | 2021-01-27 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-01-26 | view |
| JXHB2100014 | MK-7264 | gefapixant | Injection | Chemical Drugs(1) | Supplementary Application | 2021-01-27 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-01-26 | view |
| JYHB2100031 | 氯沙坦钾片 | losartan potassium | Tablet | Chemical Drugs | Supplementary Application | 2021-01-19 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd | In Review | 2021-01-18 | view |
